Profiles of Leading Players - Johns Hopkins Medicine, Mayo Clinic, MD Anderson Cancer Center, Apollo Hospital, and Fresenius Medical
Global Outpatient Clinics Market
Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The "Outpatient Clinics Market" report has been added to ResearchAndMarkets.com's offering.
The global outpatient clinics market is expected to grow from $4.4 trillion in 2024 and is projected to reach $6.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2024 to 2029.
The report provides an overview of the global outpatient clinics market and analyzes its trends. The report includes global revenue ($ billion) for base year data 2023, estimated data for 2024, and forecast for 2024 through 2029. The market is segmented based on services, clinics, specialty areas, ownership and region.
The report focuses on the market and vendor landscape's driving trends and challenges. It also analyzes environmental, social and governance (ESG) developments and discusses the regulation and emerging technologies used in outpatient clinics. The report concludes with an analysis of the competitive landscape, which provides the ranking/share of key global outpatient clinics market players. It also has a dedicated section of company profiles/major outpatient clinics that cover details of leading key market players.
The global market for outpatient clinics was valued at $4.1 trillion in 2023. The growth rate is attributed to increased patient visits and the expansion of outpatient clinics by major hospitals in different regions, such as North America, Europe and Asia-Pacific. Also, the increased rate of minimally invasive surgery for patients, growing telemedicine technology for virtual consultation, adoption of virtual meetings to patients by physicians, avoidance of long waiting lines in hospitals, and growth of the geriatric population in need of chronic disease consultation are few more factors that are driving this market's growth rate.The orthopedics segment remains the largest among outpatient clinics globally due to increasing chronic arthritis, trauma, accidents and bone-related disorders. The growing prevalence of musculoskeletal diseases, such as osteoporosis, arthritis and lumbar spinal stenosis, and the growing global elderly population with bone-related issues are primary growth drivers of the orthopedic specialty market.Report Includes
47 data tables and 64 additional tables
Analyses of trends in the global market for outpatient clinics, with revenue data for 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the market size and revenue prospects for the global market, along with a market share analysis by service type, specialty area, type of clinic facility, ownership type and region/country
Facts and figures pertaining to the market dynamics, technological progress, innovations, prospects, regulations and the impact of various macroeconomic factors
Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
An analysis of patents, emerging trends and other developments in the industry
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Profiles of leading companies, including Johns Hopkins Medicine, Mayo Clinic, MD Anderson Cancer Center, Apollo Hospital, and Fresenius Medical Care
Key Attributes:
Report Attribute
Details
No. of Pages
173
Forecast Period
2024 - 2029
Estimated Market Value (USD) in 2024
$4.4 Trillion
Forecasted Market Value (USD) by 2029
$6.3 Trillion
Compound Annual Growth Rate
7.6%
Regions Covered
Global
Key Topics Covered: Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Introduction
Factors Impacting Outpatient Clinics
Macroeconomic Factors Analysis
Porter's Five Forces Analysis
Bargaining Power of Suppliers
Bargaining Power of Buyers
Potential for New Entrants
Threat of Substitutes
Competition in the Industry
PESTLE Analysis
Value Chain Analysis in Healthcare System
Chapter 3 Market Dynamics
Global Market Dynamics
Market Drivers
Adoption of Digital Care Technology
Benefits of One-day Surgical Procedures
Increase in Treatment of Chronic Diseases in Outpatient Clinics
Outpatient Clinics as Disease Diagnosis Centers
Growing Shift from Inpatient to Outpatient Care
Market Restraints
Rise in Medication and Diagnostic Errors
Reimbursement as Obstacle for Patient
Increasing Infection Rates in Outpatient Clinics
Market Opportunities
Rise in OPDs in Modern Hospitals
Growing Adoption of Outpatient Clinics in Emerging Countries
Market Challenges
Chapter 4 Emerging Technologies and Developments
Overview
Emerging Technologies Used in Outpatient Clinics
Technological Advances in Patient Care
Patient-Centric Care Devices
Medical Diagnosis Using Software
AI in Radiology
Emerging Trends in Outpatient Clinics Development
Chapter 5 Regulatory Landscape
Overview
Functions of Regulators
Chapter 6 Market Segment Analysis
Segmentation Breakdown
Market Breakdown by Specialty Area
Orthopedic
Cardiology
General Medicine
Genitourinary and Reproductive System
Obstetrics
Ophthalmology
Dermatology
Endocrinology
Pediatrics
Respiratory Medicine
Neurology
Other Specialty Areas
Market Breakdown by Clinic
Primary Care Clinics
Community Health Clinics
Specialized Outpatient Centers
Emergency Departments
Outpatient Pharmacies
Other Healthcare Facilities
Market Breakdown by Type of Services
Wellness and Prevention
Diagnostic
Treatment
Rehabilitation
Market Breakdown by Ownership Type
Private
Public
Independent
Other Ownerships
Geographic Breakdown
Market Breakdown by Region
Chapter 7 Competitive Intelligence
Overview
Market Ranking Analysis
Key Players and Regional Impact on the Market
Ranking Analysis
Strategic Analysis
Venture Funding and Investment Landscape
Role of Venture Capital in Healthcare
Benefits of VC in Healthcare
Healthcare Companies Invested in VCs
Chapter 8 Sustainability in Healthcare System: An ESG Perspective
Introduction to ESG
ESG Practices in the Outpatient Clinics Industry
Environmental Performance
Social Performance
Governance Performance
ESG Ranking
Concluding Remarks
Chapter 9 AppendixCompanies Featured
Alexandra Hospital (National University Health System)
Apollo Hospitals
Cleveland Clinic
Davita Inc.
Fresenius Medical Care Ag
Johns Hopkins Health System
Kaiser Foundation Health Plan Inc.
Mayo Foundation For Medical Education And Research (Mfmer)
Memorial Sloan Kettering Cancer Center
Mount Sinai Medical Center
Pallium India
Select Medical Corp.
TH Medical
The University Of Texas Md Anderson Cancer Center
University Of Maryland Medical System
For more information about this report visit https://www.researchandmarkets.com/r/9rhn4t
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
Global Outpatient Clinics Market
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
10 minutes ago
- Medscape
Best US Neurology and Neurosurgery Hospitals Ranked
NYU Langone Hospitals in New York City is once again the best US hospital for neurology care, according to the 2025-2026 U.S. News & World Report annual ranking of best hospitals for neurology and neurosurgery. NYU Langone also claimed the top spot in last year's ranking. University of California San Francisco (UCSF) Health-UCSF Medical Center has climbed to second place for neurology care, improving from third last year. NewYork-Presbyterian Hospital-Columbia and Cornell in New York City has also moved up, now ranked third after holding fourth place previously. Mayo Clinic, Rochester, Minnesota, has fallen from No. 2 last year to No. 4 this year. Rush University Medical Center, Chicago, ranks fifth this year, rising two spots from No. 7 last year. Rounding out the top 10 hospitals for neurology/neurosurgery (in order) are Northwestern Medicine-Northwestern Memorial Hospital, Chicago; Johns Hopkins Hospital, Baltimore; Hospitals of the University of Pennsylvania-Penn Presbyterian, Philadelphia; University of Texas Southwestern Medical Center, Dallas; and Massachusetts General Hospital, Boston. To determine the rankings, U.S. News evaluated 1227 top neurology hospitals and ranked them based on care for brain hemorrhage, conditions affecting the central nervous system, spinal disorders and injuries, degenerative nervous system diagnoses such as multiple sclerosis, care for stroke, seizures, meningitis, and more. Best Hospitals Honor Roll As in prior years, this year U.S. News also recognized 'honor roll' hospitals that have excelled across multiple areas of care. There are 20 this year, listed in alphabetical order here: AdventHealth, Orlando, Florida Brigham and Women's Hospital, Boston Cedars-Sinai Medical Center, Los Angeles Cleveland Clinic, Cleveland Hackensack University Medical Center at Hackensack Meridian Health, Hackensack, New Jersey Hospitals of the University of Pennsylvania-Penn Medicine Houston Methodist Hospital, Houston Johns Hopkins Hospital Massachusetts General Hospital Mayo Clinic, Arizona, Phoenix Mayo Clinic, Rochester, Minnesota Mount Sinai Hospital, New York City New York-Presbyterian Hospital-Columbia and Cornell Northwestern Medicine-Northwestern Memorial Hospital NYU Langone Hospitals Rush University Medical Center Stanford Health Care-Stanford Hospital, Palo Alto, California University of California Los Angeles Medical Center UCSF Health-UCSF Medical Center University of Michigan Health, Ann Arbor, Michigan The full report is available online.
Yahoo
39 minutes ago
- Yahoo
Kevin O'Leary Says All 54 Of His Small Businesses Are Using AI To Cut Costs, Stay Competitive Amid Tariffs
Kevin O'Leary, also known as "Mr Wonderful," says artificial intelligence is helping businesses like his fight inflation and survive margin pressure brought on by new tariffs. What Happened: In a video posted Tuesday on X, formerly Twitter, the "Shark Tank" investor broke down how companies are coping with rising costs, citing General Motors (NYSE:GM) as an example of how businesses may navigate a 45% margin hit. "This may be the roadmap for every business," O'Leary said on Fox Business. One-third of the margin hit, they're going to eat themselves, so they're going to have to find ways to be more productive, he said. One-third, they're going to push out on price increases, which "I agree is inflationary." But the last third? That's where AI comes in. Trending: Be part of the breakthrough that could replace plastic as we know it— He emphasized that every one of the 54 small businesses in his private portfolio is now leveraging vertical applications of AI to reduce operational costs — whether in insurance, wireless charging, or other sectors. "We've never had tariffs before with an AI multiplier in it," he said. "This forces us to figure out a way to be more productive." Why It's Important: O'Leary's comments come as many companies grapple with rising tariffs and inflationary pressure, especially in sectors heavily exposed to global supply chains. His view reflects a growing consensus that artificial intelligence is not just a tech trend but a crucial tool for business survival and long-term productivity gains. Last week, Alphabet Inc. (NASDAQ:GOOG) (NASDAQ:GOOGL) CEO Sundar Pichai reportedly urged employees to increase their use of AI to boost productivity, highlighting that the company must 'accomplish more' without expanding headcount. Earlier this month, Yahoo Japan also instructed its 11,000 employees to incorporate generative AI into their daily workflows, to double productivity through automation by 2028. AI-driven automation has also contributed to a surge in tech industry layoffs, impacting as many as 80,000 workers. Microsoft Corporation (NASDAQ:MSFT), for example, has laid off 15,000 employees while simultaneously allocating $80 billion toward AI development. Read next: $100k+ in investable assets? Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes – no cost, no obligation. These five entrepreneurs are worth $223 billion – they all believe in one platform that offers a 7-9% target yield with monthly dividends Photo courtesy: Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Kevin O'Leary Says All 54 Of His Small Businesses Are Using AI To Cut Costs, Stay Competitive Amid Tariffs originally appeared on Sign in to access your portfolio
Yahoo
42 minutes ago
- Yahoo
Microsoft climbs to $4 trillion in after-hours trading on blowout earnings
Microsoft delivered a blockbuster quarter to close its 2025 fiscal year, riding the wave of surging demand for cloud and AI services and sending its stock to new heights in after-hours trading. For the quarter ended June 30, 2025, Microsoft reported revenue of $76.4 billion, an 18% jump over the previous year. Net income climbed even more swiftly, up 24% to $27.2 billion. Earnings per share reached $3.65, outpacing analyst estimates of $3.37. 'In our largest quarter of the year,' CEO Satya Nadella told analysts on the subsequent earnings call, 'we significantly exceeded expectations.' Investors responded decisively to the upbeat results and bullish AI outlook. Microsoft's shares spiked over 7% in after-hours trading, pushing the stock toward record highs and lifting Microsoft's market capitalization past the $4 trillion mark—cementing its place as one of just two companies to reach that level globally, along with Nvidia. The reaction underscored Wall Street's confidence in Microsoft's strategy, particularly its aggressive investments in cloud infrastructure and its push to commercialize AI tools such as Copilot across its productivity and developer platforms. Nadella was emphatic in the earnings press release: 'Cloud and AI is the driving force of business transformation across every industry and sector. We're innovating across the tech stack to help customers adapt and grow in this new era.' On the subsequent earnings call, one analyst expressed surprise at the size of the results. 'Satya, back to the strength across the board in the quarter… It's just the magnitude of upside that has shocked many here.' To that point, the company's Intelligent Cloud segment—home to Azure—generated $29.9 billion in revenue, up a robust 26%. Azure and other cloud services revenue soared 39% for the quarter, while annual Azure revenue surpassed $75 billion, growing 34% year-over-year. Nadella cited major enterprise customers leveraging both traditional and AI-powered workloads on Azure, highlighting that this is no longer just about experimentation—companies are moving quickly to deploy AI at scale. Nadella claimed on the analyst call that 'we continue to lead the AI infrastructure wave and gained market share every quarter this year,' noting that Microsoft operates more data centers than any other cloud provider, having opened new facilities across six continents. He said it operates over 400 data centers across 70 regions. Strength across the board The Productivity and Business Processes segment, anchored by Microsoft 365 and LinkedIn, generated $33.1 billion (+16%), and More Personal Computing brought in $13.5 billion (+9%), bolstered by a rebound in devices demand and rising Xbox content revenue. Throughout fiscal 2025, Microsoft amassed $281.7 billion in revenue (+15%) and $101.8 billion in net income (+16%). The company also returned $9.4 billion to shareholders in the fourth quarter through dividends and buybacks. CFO Amy Hood emphasized Microsoft's operational discipline and the scaling of AI investments, and revealed on the earnings call that the company expects over $30 billion of capital expenditure for the first quarter of 2026, 'driven by the continued strong demand signals we see. When asked about the return on investment on this massive spending, Hood responded that Microsoft has $368 billion of contracted backlog across the 'breadth of the Microsoft Cloud,' not just Azure. She added that she feels very confident that this spending is 'directly tied to business that is already contracted and on the books — and that we need to deliver.' Hood also reassured employees and investors of the company's forward momentum, noting in an internal post-earnings memo, as reported by Business Insider, that 'FY26 will require intensity, clarity, and bold execution,' reflecting both the opportunities and competitive pressures ahead as Microsoft doubles down on AI and security priorities. For this story, Fortune used generative AI to help with an initial draft. An editor verified the accuracy of the information before publishing. This story was originally featured on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
